Downgrades Outperform Perform X

CDXC ChromaDex

Oppenheimer

Downgrades Buy Neutral X

CDXC ChromaDex

B. Riley Securities

$6 $2.40

Initiated Buy X

CDXC ChromaDex

ROTH Capital

$7

Initiated Buy X

CDXC ChromaDex

B. Riley FBR

$7

CDXC  ChromaDex Corporation

Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks.